Skip Navigation

Nephrology Dialysis Transplantation 2009 24(2):391-395; doi:10.1093/ndt/gfn740
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ricci, Z.
Right arrow Articles by Ronco, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ricci, Z.
Right arrow Articles by Ronco, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Kidney diseases beyond nephrology: intensive care

Zaccaria Ricci1 and Claudio Ronco2

1 Department of Paediatric Cardiosurgery, Bambino Gesù Hospital, Rome, Italy 2 Department of Nephrology, Dialysis and Transplantation, S.Bortolo Hospital, Vicenza, Italy

Correspondence and offprint requests to: Zaccaria Ricci, Piazza S. Onofrio 400100, Rome, Italy. Tel: +39-064456115; Fax: +39-0444993949; E-mail: z.ricci@libero.it

Keywords: Tight glycemic control; pulmonary artery catheter; renal replacement dose; fluid balance; extracorporeal membrane oxygenation

The first 150 words of the full text of this article appear below.



   Evidence-based and good sense-based critical care medicine
 
Critical care medicine has improved greatly, thanks to the implementation of guidelines and good clinical practice protocols. For this reason, the present clinical practice requires evidence-based medicine to answer unresolved debates and to further improve applied protocols. Randomized controlled trials are (even if not always [1]) essential in order to achieve a high level of scientific evidence good enough to support the application of new life-saving strategies or to change significantly current practice [2]. Such trials are now strongly needed because mortality has improved to such a level that large investments will be required to achieve relatively small improvements in clinical outcomes. Nevertheless, this approach has justified and encouraged changes in therapeutic strategies sometimes contradicted after only a few years. This not only demonstrates how difficult it is to reach a definitive consensus in the world of critical care medicine but it may also induce perplexity . . . [Full Text of this Article]



   Dialysis dose: a nihilistic approach?
 


   The issue of fluid balance
 


   Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?